Trials / Completed
CompletedNCT07447518
Double j Stent Related Symptoms
Comparison of Mirabegron ,Tamsulosin and Solifenacinin Relieving Double -J Stent Related Symptoms : Approspective Randmized Placebo Controlledtrial
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 535 (actual)
- Sponsor
- Kafrelsheikh University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In urology, ureteral stents are used to treat obstructive diseases. Hematuria (54%), fever, discomfort, and lower urinary system symptoms are the predominant symptoms related to ureteral stent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tadalafil 5mg | once daily 5mg |
| DRUG | solidosin | once daily |
| DRUG | Solfenacin | once dialy |
| DRUG | Mirabegron | once daily |
| DRUG | Placebo | once daily |
Timeline
- Start date
- 2022-09-22
- Primary completion
- 2023-01-01
- Completion
- 2023-09-01
- First posted
- 2026-03-03
- Last updated
- 2026-03-03
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07447518. Inclusion in this directory is not an endorsement.